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We rechecked and recalculated the data by noninferiority and superiority test. The lactate kinetics group mortality rate (P1) was 18.3% and the Scvo2 group mortality rate (P2) was 27.9%. The standard error for the mortality difference between the two groups was 0.0441, and thus the mortality difference was -0.0944 (95% confidence interval -0.1809 to -0.0080). The upper limit of the interval is less than 0, and thus the superiority conclusion is established. At this point, regardless of the non-inferior value (0.15 or 0.10), non-inferior conclusions must be established.
Additionally, the non-inferiority threshold of 10% is indeed more reasonable according to a previous study [3] .Therefore, regardless of whether the non-inferiority threshold is set at 10% or 15%, no effect on the final conclusion was seen in this study.
Last, but not the least, the latest sepsis guidelines released by the SCC in 2016 have weakened early goaldirected therapy (EGDT) and highlighted the importance of normalization of lactate [4] , which also supports the conclusion we draw that stepwise lactate kineticsoriented hemodynamic therapy can reduce mortality in patients with sepsis-associated hyperlactatemia compared with ScvO2-oriented therapy.
Abbreviations EGDT: Early goal-directed therapy; SCC: Surviving Sepsis Campaign; ScvO2: Central venous oxygen saturation
